BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease-Reference-Cited by-同舟云学术

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease

Published:2014-05-13 Issue:11 Volume:5 Page:3607-3610
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Janku Filip¹,Vibat Cecile Rose T.²,Kosco Karena²,Holley Veronica R.¹,Cabrilo Goran¹,Meric-Bernstam Funda¹,Stepanek Vanda M.¹,Lin Patrick P.³,Leppin Lorieta²,Hassaine Latifa²,Poole Jason C.²,Kurzrock Razelle⁴,Erlander Mark G.²

Affiliation:

1. Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center

2. Trovagene Inc. San Diego, CA

3. Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center

4. Moores Cancer Center, The University of California San Diego, La Jolla, CA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease;Journal of Neurology;2023-09-19

2. Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis;Blood Advances;2023-07-28

3. MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis;Leukemia;2021-11-16

4. Assessment of Circulating Nucleic Acids in Cancer: From Current Status to Future Perspectives and Potential Clinical Applications;Cancers;2021-07-10

5. Histiocytosis;The Lancet;2021-07